eTurboNews - Independent and Global Travel, Tourism, Lifestyle, Entertainment News you only find here

Travel News Distribution powered by eTurboNews:

Diabetic Gastroparesis, Heart Attack And Liposarcoma - Pipeline Review To H1 2015: Radiant Insights

(Forimmediaterelease.net) RadiantInsights.com includes new market research report on “Diabetic Gastroparesis, Heart Attack And Liposarcoma - Pipeline Review To H1 2015″ to its huge collection of research reports.
Diabetic Gastroparesis - Pipeline Review, H1 2015

Global Markets Direct's, 'Diabetic Gastroparesis - Pipeline Review, H1 2015', provides an overview of the Diabetic Gastroparesis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Diabetic Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Gastroparesis and special features on late-stage and discontinued projects.

Scope

• The report provides a snapshot of the global therapeutic landscape of Diabetic Gastroparesis

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details&other developmental activities

• The report reviews key players involved in the therapeutics development for Diabetic Gastroparesis and enlists all their major and minor projects


For More Information visit at:
www.radiantinsights.com/research/diabetic-gastroparesis-pipeline-review-h1-2015


Heart Attack - Pipeline Review, H1 2015

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news&deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Heart Attack

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details&other developmental activities

• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

• Coverage of the Heart Attack pipeline on the basis of target, MoA, route of administration and molecule type


View Full Report with TOC at:
www.radiantinsights.com/research/heart-attack-pipeline-review-h1-2015


Liposarcoma - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liposarcoma and special features on late-stage and discontinued projects.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Liposarcoma

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details&other developmental activities

• The report reviews key players involved in the therapeutics development for Liposarcoma and enlists all their major and minor projects

• A detailed assessment of monotherapy and combination therapy pipeline projects

• Latest news and deals relating related to pipeline products


Complete Report Available at:
www.radiantinsights.com/research/liposarcoma-pipeline-review-h1-2015


About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit: www.radiantinsights.com/

Blog: www.terrapass.org/

Company Name: Radiant Insights, Inc. Contact Person: Michelle Thoras, Corporate Sales Specialist - USA Email: sales@radiantinsights.com Phone: (415) 349-0054(415) 349-0054, Toll Free: 1-888-202-95191-888-202-9519 FREE Address:28 2nd Street, Suite 3036 City: San Francisco State: Califonia Country: United States Website: www.radiantinsights.com/research/diabetic-gastroparesis-pipeline-review-h1-2015

+++ Upload Your Press Release +++



Need assistance?

You need a little assistance?Call for help
+1-808-521-2800

Subscribe Now!

News Distribution Service

Distribute your press release with our service?

Submit Your Press-release

Latest Travel News


Top